Ebola, FDA Votes, Drug Costs

Kilder

• STAT: Ebola outbreak nears milestone, while a vaccine remains months away
• STAT: STAT+: FDA expert committee votes in favor of Replimune’s melanoma treatment
• The Wall Street Journal: FDA Panel Votes In Favor of Replimune’s Melanoma Treatment - WSJ
• Raps: Recon: FDA adcomm votes against Capricor’s DMD drug; Cytokinetics gets UK approval, NICE backing for heart drug - RAPS
• STAT: STAT+: Pharmalittle: We’re reading about an FDA panel nixing a Duchenne drug, FTC suing Hims & Hers, and more
• STAT: Rising oil prices can boost the cost of some medicines. One expert says it's time to lower reliance on fossil fuels - STAT
• STAT: STAT+: Rising oil prices can boost the cost of some medicines. One expert says it’s time to lower reliance on fossil fuels
• Raps: Recon: FDA adcomm votes against Capricor’s DMD drug; Cytokinetics gets UK approval, NICE backing for heart drug - RAPS

Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.